Luteinizing hormone as a key player in the cognitive decline of Alzheimer's disease
- 1 November 2015
- journal article
- review article
- Published by Elsevier BV in Hormones and Behavior
- Vol. 76, 48-56
- https://doi.org/10.1016/j.yhbeh.2015.05.010
Abstract
No abstract availableFunding Information
- Oberlin College
This publication has 100 references indexed in Scilit:
- Toward the Treatment and Prevention of Alzheimer's Disease: Rational Strategies and Recent ProgressAnnual Review of Medicine, 2013
- Hippocampal Atrophy and Ventricular Enlargement in Normal Aging, Mild Cognitive Impairment (MCI), and Alzheimer DiseaseAlzheimer Disease & Associated Disorders, 2012
- The Dynamics of Cortical and Hippocampal Atrophy in Alzheimer DiseaseArchives of Neurology, 2011
- Hippocampal degeneration is associated with temporal and limbic gray matter/white matter tissue contrast in Alzheimer's diseaseNeuroImage, 2011
- Timing of hormone therapy and dementia: The critical window theory revisitedAnnals of Neurology, 2010
- Genetic Ablation of Luteinizing Hormone Receptor Improves the Amyloid Pathology in a Mouse Model of Alzheimer DiseaseJournal of Neuropathology and Experimental Neurology, 2010
- Down‐regulation of serum gonadotropins is as effective as estrogen replacement at improving menopause‐associated cognitive deficitsJournal of Neurochemistry, 2010
- β-catenin is required for memory consolidationNature Neuroscience, 2008
- Human chorionic gonadotropin (a luteinizing hormone homologue) decreases spatial memory and increases brain amyloid-β levels in female ratsHormones and Behavior, 2008
- Gonadotropin-releasing hormone regulates spine density via its regulatory role in hippocampal estrogen synthesisThe Journal of cell biology, 2008